一项跨国对医生关于慢性型肝炎管理知识的调查
Mohamed El-Kassas1, Yusuf Yilmaz2, Chun-Jen Liu3
1Endemic Medicine Department, Faculty of Medicine, Helwan University, Cairo, Egypt; The Global Liver Council, Center for Outcomes Research in Liver Diseases, Washington DC, United States.
Annals of hepatology
|October 4, 2025
概括
医生们很了解C型肝炎病毒 (HCV) 的指导方针,但存在知识差距. 持续教育对于更好的HCV患者护理和遵守管理协议至关重要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 传染性疾病 传染性疾病
- 病毒性肝炎管理管理
背景情况:
- 对型肝炎病毒 (HCV) 管理的最新知识对于最佳的患者结果至关重要.
- 医生对当前HCV指南的认识,态度和障碍会影响医疗保健.
- 治疗后的随访对于管理HCV并发症和风险至关重要.
研究的目的:
- 评估医生对当前的HCV管理指南的认识和态度.
- 评估医生的自我有效性,与HCV治疗和随访相关的看法和障碍.
- 识别知识缺口和改善HCV护理协议的领域.
主要方法:
- 一项由48个问题组成的调查分发给治疗HCV患者的医疗保健提供者.
- 该调查评估了实践,熟悉指南和对HCV管理的态度.
- 来自8个国家的183名医生完成了调查.
主要成果:
- 大多数医生 (95%) 了解HCV治疗指南 (EASL 84%,AASLD 72%).
- 94%的人认为HCV治疗后的随访是有效的,93%的人建议这样做.
- 尽管对指导方针有很高的认识 (90%),但39%的人报告了不一致性;86%的人承认在持续病毒学反应 (SVR) 后需要随访.
结论:
- 医生表现出对HCV指导方针的高度认识,但存在潜在的知识差距和不一致性.
- 持续的教育和支持对于加强对HCV管理协议的遵守至关重要.
- 有效的治疗后随访策略是公认的,但需要持续的教育来优化护理.
相关概念视频
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
180
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
180
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
212
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
212
01:29Chronic Pancreatitis II: Collaborative Care
311
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
311
01:28Esophageal Varices-II: Clinical Features and Management
368
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
368
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
253
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
253
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
212
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
212